337 The Discovery and Preclinical Characterization of CC-223, a Novel mTOR Kinase Inhibitor Under Clinical Investigation
Autor: | Mortensen, D.S., Fultz, K.E., Hickman, M., Khambatta, G., Xu, W., Perrin-Ninkovic, S.M., Zhao, J., Narla, R.K., Raymon, H., Sankar, S. |
---|---|
Zdroj: | In European Journal of Cancer November 2012 48 Supplement 6:103-103 |
Databáze: | ScienceDirect |
Externí odkaz: |